Standex director sells 50 shares under 10b5-1 plan

Standex International director Thomas E. Chorman reported an open-market sale of 50 shares of Common Stock at $257.94 per share on April 1, 2026.

Rhea-AI Filing Summary

Standex International director Thomas E. Chorman reported an open-market sale of 50 shares of Common Stock at $257.94 per share on April 1, 2026. The transaction was executed pursuant to an existing Rule 10b5-1 trading plan dated November 6, 2025.

After this sale, Chorman directly holds 12,566 shares of Standex International common stock, indicating the transaction represents a small portion of his reported holdings and appears to be a routine, pre-planned sale.

Insider Trade Summary 10b5-1

Net Seller: 50 shares

Net Sell 1 txn

Insider CHORMAN THOMAS E

Role Director

Sold 50 shs ($13K)

Type	Security	Shares	Price	Value
Sale	Common Stock	50	$257.94	$13K

Holdings After Transaction: Common Stock — 12,566 shares (Direct)

Footnotes (1)

1. F1. Sale of stock pursuant to existing 10b5-1 trading plan dated November 6, 2025.

Key Figures

Shares sold: 50 shares Sale price: $257.94 per share Shares held after sale: 12,566 shares

3 metrics

Shares sold 50 shares Open-market sale of Common Stock on April 1, 2026

Sale price $257.94 per share Price for the 50 shares sold

Shares held after sale 12,566 shares Direct holdings of Thomas E. Chorman following the transaction

Key Terms

Rule 10b5-1 trading plan, open-market sale, Common Stock

3 terms

Rule 10b5-1 trading plan regulatory

"Sale of stock pursuant to existing 10b5-1 trading plan dated November 6, 2025."

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

open-market sale financial

"transaction_action": "open-market sale""

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

Common Stock financial

"security_title": "Common Stock""

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Standex (SXI) director Thomas E. Chorman report?

Director Thomas E. Chorman reported selling 50 shares of Standex Common Stock in an open-market sale at $257.94 per share. The transaction is disclosed on a Form 4 insider filing and reflects a relatively small trade.

Was the recent SXI insider stock sale made under a Rule 10b5-1 plan?

Yes. The filing states the sale was made pursuant to an existing Rule 10b5-1 trading plan dated November 6, 2025. Such pre-arranged plans automate trades over time, reducing the significance of trade timing as a discretionary signal.

How many Standex (SXI) shares does Thomas E. Chorman hold after the sale?

Following the reported transaction, Thomas E. Chorman directly holds 12,566 shares of Standex International Common Stock. This shows the sale of 50 shares represents only a small fraction of his reported direct ownership position.

What was the price for the SXI shares sold by director Thomas E. Chorman?

The 50 Standex International Common Stock shares were sold at an average price of $257.94 per share. This price is taken directly from the Form 4 disclosure describing the open-market sale transaction.

Does the Standex (SXI) Form 4 show any option exercises or derivative transactions?

No derivative transactions are listed in this Form 4. The filing shows only a single non-derivative open-market sale of 50 Common Stock shares, with no stock option exercises or other derivative security activity reported.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/03/2026 - 01:51 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

CHORMAN THOMAS E

(Last) (First) (Middle)

STANDEX INTERNATIONAL CORPORATION

23 KEEWAYDIN DRIVE, SUITE 300

(Street)

SALEM NEW HAMPSHIRE 03079

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
STANDEX INTERNATIONAL CORP/DE/ [ SXI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	04/01/2026		S(1)		50	D	$257.94	12,566	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Sale of stock pursuant to existing 10b5-1 trading plan dated November 6, 2025.

	/s/ Alan J. Glass	04/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)